Patents by Inventor Kirsten Mertz

Kirsten Mertz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification and treatment of estrogen responsive prostate tumors
    Patent number: 8106037
    Abstract: The present invention is directed to specific chromosomal rearrangements that are associated with prostate tumors that respond to compounds acting at estrogen receptors. Patients having the TMPRSS2-ERG fusion, may be treated with agonists of the estrogen beta receptor or antagonists of the estrogen alpha receptor.
    Type: Grant
    Filed: July 23, 2008
    Date of Patent: January 31, 2012
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Mark Rubin, Kirsten Mertz, Sunita Setlur
  • Identification and treatment of estrogen responsive prostate tumors
    Publication number: 20090036415
    Abstract: The present invention is directed to specific chromosomal rearrangements that are associated with prostate tumors that respond to compounds acting at estrogen receptors. Patients having the TMPRSS2-ERG fusion, may be treated with agonists of the estrogen beta receptor or antagonists of the estrogen alpha receptor.
    Type: Application
    Filed: July 23, 2008
    Publication date: February 5, 2009
    Applicant: The Brigham and Women's Hospital, Inc.
    Inventors: Mark Rubin, Kirsten Mertz